# 



## 

## 

## 

|||Page|
|---|---|---|
|Trustees'|annual<br>report||
|Independent<br>examiner's<br>report to the trustees|||
|Statement|offinancial<br>activities||
|Statement|offinancial<br>position||
|Statement|ofcash flows||
|Notes to the financial statements|||





## 

## 

|Reference a|nd adm|inistrative|details||
|---|---|---|---|---|
|Registered|charity|name|Medical and Life Sciences Research|Fund|
|Charity registration||number|1139383||
|Principal office|||Medical and Life Sciences Research|Fund|
||||University<br>ofWarwick Science Park||
||||Barclays Venture Centre||
||||Sir William<br>Lyons Road||
||||Coventry||
|The trustees|||Prof C G Dowson||
||||Dr A Shehu||
||||Dr C G Fink||
||||Dr M Atkins||
|Independent|examiner||Mr KC Varney - ACMA ofVarney Barfield &Co.<br>6 Corunna<br>Court||
||||Corunna<br>Road||
||||Warwick||
||||CV34 5HQ||



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 


## 



## 

## 

## 

## 

## 



## 

## 

## 

|||Ye|ar en|ded 5April 2|021|||
|---|---|---|---|---|---|---|---|
||||||2021||2020|
|||||Unrestricted|Restricted|||
|||||funds|funds|Total funds|Total funds|
||||Note|||||
|Income and endowments||||||||
|Donations<br>and legacies|||4|484,606|16,000|500,606|73,270|
|Total income||||484,606|16,000|500,606|73,270|
|Expenditure||||||||
|Expenditure<br>on raising funds:||||||||
|Costs of raising donations||and||||||
|legacies<br>Expenditure<br>on charitable|activities||5<br>6,7|(78,068)|(16,000)|(94,068)|(523)<br>(53,263)|
|Total expenditure||||(78,068)|(16,000)|(94,088)|(53,786)|
|Net income and net movement||in funds||406,538||406,538|19,484|
|Reconciliation<br>offunds||||||||
|Total funds brought<br>forward||||112,980|4,811|117,791|98,307|
|Total funds carried forward||||519,518|4,811|524,329|117,791|





## 

## 

|||Statem|ent|ofFinancial Po|sition|||
|---|---|---|---|---|---|---|---|
||||5|April 2021||||
|||||2021||2020||
||||Note|||||
|Current assets||||||||
|Cash at bank and|in|hand||525,649||119,111||
|Creditors: amounts||falling due within||||||
|one year|||15|(1,320)||(1,320)||
|Net current assets|||||524,329||117,791|
|Total assets less|current liabilities||||524,329||117,791|
|Net assets|||||524,329||117,791|
|Funds ofthe charity||||||||
|Restricted<br>funds|||||4,811||4,811|
|Unrestricted<br>funds|||||519,518||112,980|
|Total charity funds|||16||524,329||117,791|





## 

## 

## 

|||Yea|r ended 5April 202|1||
|---|---|---|---|---|---|
|||||2021|2020|
|||||f.||
|Cash flows from operating||activities||||
|Net income||||406,538|19,484|
|Adjustments<br>for:||||||
|Cash generated|from operations|||406,538|19,484|
|Net cash from operating<br>activities||||406,538|19,484|
|Net increase<br>in <br>Cash and cash|cash and cash equivalents<br> equivalents<br>at beginning||ofyear|406,538<br>119,111|19,484<br>99,627|
|Cash and cash|equivalents|at end ofyear||525,649|119,111|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

|Donations|and leg|acies|||||
|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2021|
|||||F|F|F|
|Donations|||||||
|Donations|received|- charitable|purposes|482,840|16,000|498,840|
|Donations|received|—fundraising|||||
|Donations|received|- overheads||1,766||1,766|
|Donations|received|- gift aid|||||
|||||484,606|16,000|500,606|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2020|
|Donations|||||||
|Donations|received|- charitable|purposes|64,850|6,029|70,879|
|Donations|received|—fundraising||523||523|
|Donations|received|- overheads||1,793||1,793|
|Donations|received|- gift aid||75||75|
|||||67,241|6,029|73,270|



## 

|Costs of raising donation|s<br>and legacies|||||
|---|---|---|---|---|---|
|||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||Funds|2021|Funds|2020|
||||||F|
|Costs of raising donations|and legacies-|||||
|Donations||||523|523|





## 

## 

## 

|||||Unrestricted|Restricted|Total Funds|
|---|---|---|---|---|---|---|
|||||Funds|Funds|2021|
|Cancer and cardiovascular<br>research<br>activities<br>Food security and agricultural<br>research<br>Bacterial research<br>Obesity research<br>Educational<br>support<br>Reproduction<br>research||||F<br>12,528<br>2,000<br>6,700<br>7,912<br>31,156|16,000|28,528<br>2,000<br>6,700<br>7,912<br>31,156|
|Neuroscience<br>research<br>Support costs||||15,917<br>1,855||15,917<br>1,855|
|||||78,068|16,000|94,068|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2020|
|Cancer and cardiovascular<br>research<br>activities<br>Food security and agricultural<br>research<br>Bacterial research<br>Obesity research||||7,893<br>13,800|6,029<br>2,000|6,029<br>7,893<br>15,800|
|Educational<br>support<br>Reproduction<br>research<br>Neuroscience<br>research||||13,686<br>7,988||13,686<br>7,988|
|Support costs||||1,867||1,867|
|||||45,234|8,029|53,263|



## 

|Expenditure<br>on charitable||activities<br>b|y activity type||||
|---|---|---|---|---|---|---|
||||Grant funding<br>ofactivities|Support costs|Total funds<br>2021|Total fund<br>2020|
|Cancer and cardiovascular|research||F||||
|activities<br>Food security and agricultural<br>Bacterial research<br>Obesity research<br>Educational<br>support<br>Reproduction<br>research<br>Neuroscience<br>research<br>Governance<br>costs||research|28,528<br>2,000<br>6,700<br>7,912<br>31,156<br>15,917|1,855|28„528<br>2,000<br>6,700<br>7,912<br>31,156<br>15,917<br>1,855|6,029<br>7,893<br>15,800<br>13,686<br>7,988<br>1,867|
||||92,213|1,855|94,068|53,263|





## 

## 

## 

|Notes to the F<br>Year|inancial Statements<br> ended 5 April 2021|(continued)||
|---|---|---|---|
|Analysis ofgrants||||
|||2021|2020|
|||f.||
|Grants to individuals<br>Cancer and cardiovascular<br>research activities<br>Food security and agricultural<br>research<br>activities<br>Bacterial research<br>activities<br>Obesity research<br>activities<br>Educational<br>support<br>Reproduction<br>research<br>activities<br>Neurosciences<br>research<br>activities||28,528<br>2,000<br>6,700<br>7,912<br>31,156<br>15,917|6,029<br>7,893<br>15,800<br>13,686<br>7,988|
|||92,213|51,396|
|||92,213|51,396|



## 

||<br>the School of Life Sciences|<br>the School of Life Sciences|.||||
|---|---|---|---|---|---|---|
|.|Support costs||||||
||||||2021|2020|
||Accountancy|fees|||1,379<br>90|1,320<br>74|
||Bank charge||||386|355|
||Computer costs|||||118|
||Printing,<br>postage and stationery||||1,855|1,867|
|10.|Independent|examination|fees||||
||||||2021|2020|
||||||f||
||Fees payable <br>Independent|to the independent<br>examination<br>ofthe||examiner for:<br> financial statements|1,320|1,320|



## 

## 

## 

## 



## 

## 

## 

## 

|||Website|
|---|---|---|
|||development|
|Cost|||
|At 6April|2020 and 5April 2021|3,208|
|Amortisation|||
|At 6April|2020 and 5April 2021|3,208|
|Carrying|amount||
|At 5April|2021||
|At 5April|2020||



## 

|Tangible|fixed asset|s|||
|---|---|---|---|---|
||||Equipment|Total|
||||E||
|Cost|||||
|At 6April|2020 and 5April 2021||409|409|
|Depreciation|||||
|At 6April|2020 and 5April 2021||409|409|
|Carrying|amount||||
|At 5April|2021||||
|At 5 April|2020||||
|Creditors: amounts||falling due within one year|||
||||2021|2020|
|||||F|
|Accruals and deferred||income|1,320|1,320|



## 

## 

|Unrestricted|funds||||||||
|---|---|---|---|---|---|---|---|---|
|||||||||At|
|||At|6|April 2020|Income|Expenditure||5April 2021|
|||||F||||E|
|Unrestricted|Fund|||112,980|484,606|(78,068)||519,518|
|||At|6|April 2019|Income|Expenditure|At|5 April 2020|
|Unrestricted|Fund|||91,496|67,241|(45,757)||112,980|





## 

## 

## 

## 

## 

## 

|||||||||||||At|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||At 6 April 2020|||Income||Expenditure|5April 2021|
||||||||F|||F|F||
||Restricted|Fund|||||4,811|||16,000|(16,000)|4,811|
||||||||At 6 April 2019||Income||Expenditure<br>At 5 April 2020||
||||||||F|||F|F||
||Restricted|Fund|||||6,811|||6,029|(8,029)|4,811|
||Restricted|funds relate to donations||||received for the purposes|||of|supporting|particular<br>research areas||
||At 5 April|2020, the|charity||held Restricted||Funds for the|following||purposes:<br>2021||2020|
||||||||||||F|F|
||Cancer and cardiovascular||||research||||||4,811|4,811|
|17.|Analysis|ofnet assets between funds|||||||||||
|||||||||Unrestricted|||Restricted|Total Funds|
|||||||||||Funds|Funds|2021|
||||||||||||F|f.|
||Current assets||||||||520,838||4,811|525,649|
||Creditors|less than|1|year||||||(1,320)||(1,320)|
||Net assets||||||||519,518||4,811|524,329|
|||||||||Unrestricted|||Restricted|Total Funds|
|||||||||||Funds|Funds|2020|
||||||||||||F|F|
||Current assets||||||||114,300||4,811|119,111|
||Creditors|less than|1|year||||||(1,320)||(1,320)|
||Net assets||||||||112,980||4,811|117,791|
|18.|Analysis|ofchanges||in|net debt||||||||
|||||||||At|6Apr 2020||Cash flows|At 5Apr 2021|
|||||||||||F|F|F|
||Cash at|bank and|in|hand||||||119,111|406,538|525,649|



## 

## 

